PatternsRadar
Sign in

NATCOPHARMNatco Pharma Limited

NSE
814.30INR-7.65 (-0.93%)Close · 20 Nov 2026
13 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹15,974 CrMarket cap
19.3P/E (TTM)
48.3%Delivery

Filings & corporate actions

86 results filed
CSV
Next results · Q3 FY27
Expected 9 Feb 2027 – 14 Feb 2027
Estimate: filed 40–45 days after quarter end, last 5 times
Dividend
₹1.25 per share · last 19 Nov 2026
2026
  • 19 NovdividendDividend · ₹1.25 per share · record 19 Nov 2026+0.2%
  • 13 NovresultsResults · Q2 FY27 · consolidated and standalone+0.2%NSE
  • 1 NovshareholdingShareholding · 23 Oct 2026+0.4%NSE
  • 16 OctshareholdingShareholding · 30 Sept 20260.0%NSE
  • 1 OctrightsRights 2:21 @ Premium Rs 748/- · record 1 Oct 2026-0.7%
  • 20 AugdividendDividend · ₹1.50 per share-1.1%
  • 14 AugresultsResults · Q1 FY27 · consolidated and standalone-1.5%NSE
  • 9 JulshareholdingShareholding · 30 Jun 2026-0.5%NSE
  • 29 MayresultsResults · Q4 FY26 · consolidated and standalone-8.1%NSE
  • 9 AprshareholdingShareholding · 31 Mar 2026+1.0%NSE
  • 18 FebdividendDividend · ₹1.50 per share+0.7%
  • 12 FebresultsResults · Q3 FY26 · consolidated and standalone-1.9%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025-1.6%NSE

Reaction to results · all yearsrose on day 0 in 28 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2713 Nov 2026+0.2%+0.7%—6.5×
Q1 FY2714 Aug 2026-1.5%-2.1%-9.3%1.9×
Q4 FY2629 May 2026-8.1%-14.5%-8.3%3.9×
Q3 FY2612 Feb 2026-1.9%+6.2%+12.7%0.9×
Q2 FY2614 Nov 2025+1.0%+3.5%+11.4%1.2×
Q1 FY2612 Aug 2025+1.8%-0.8%-2.9%0.5×
Q4 FY2528 May 2025+3.6%-0.1%+1.0%6.8×
Q3 FY2512 Feb 2025-20.0%-34.9%-34.3%18.2×
Q2 FY2512 Nov 2024-1.7%-2.4%+3.7%4.4×
Q1 FY2512 Aug 2024-1.3%-1.5%+6.5%1.5×
Q4 FY2427 May 2024+0.3%-5.7%+14.4%9.9×
Q3 FY2414 Feb 2024+0.3%+14.0%+10.5%2.6×
Q2 FY2414 Nov 2023-4.5%+0.7%-3.7%4.2×
Q1 FY249 Aug 2023-2.0%-3.2%-1.3%1.5×
Q4 FY2329 May 2023-2.1%-2.0%+8.3%1.8×
Q3 FY239 Feb 2023-0.9%+1.0%+2.8%0.9×
Q2 FY2310 Nov 2022-0.7%-2.4%-3.4%1.8×
Q1 FY239 Aug 2022-10.3%-13.0%-19.8%8.5×
Q4 FY2231 May 2022+3.7%+3.7%-3.9%14.3×
Q3 FY2214 Feb 2022-2.4%-8.4%-8.5%3.6×
Q2 FY2211 Nov 2021+0.6%-1.9%+7.2%1.5×
Q1 FY2212 Aug 2021-5.1%-13.4%-6.3%0.9×
Q4 FY2117 Jun 2021+1.2%+1.3%+2.4%1.0×
Q3 FY2111 Feb 2021-3.6%-8.1%-6.7%3.6×
Q2 FY2112 Nov 2020-0.6%+0.5%+4.5%2.6×
Q1 FY2112 Aug 2020-4.2%-1.2%-8.2%0.8×
Q4 FY2017 Jun 2020+1.0%+3.7%+11.8%0.7×
Q3 FY2012 Feb 2020-4.9%-6.5%-20.9%3.7×
Q2 FY2012 Nov 2019-3.2%-4.1%+0.6%2.0×
Q1 FY209 Aug 2019-0.6%-2.1%+3.1%1.4×
Q4 FY1927 May 2019+0.9%+3.3%+2.2%8.6×
Q3 FY1919 Feb 2019+1.1%+0.9%+2.8%1.0×
Q2 FY1919 Nov 2018-1.7%-4.1%-4.9%1.1×
Q1 FY1924 Aug 2018+1.0%+3.3%-0.7%0.8×
Q4 FY181 Jun 2018-1.0%-2.6%-0.3%1.6×
Q3 FY189 Feb 2018-1.9%-3.1%-10.2%0.9×
Q2 FY183 Nov 2017+0.2%-2.4%-1.0%1.0×
Q1 FY1821 Aug 2017-4.4%-4.4%+5.7%0.4×
Q4 FY1715 Jun 2017+2.1%+0.4%+2.0%2.0×
Q3 FY1722 Feb 2017+4.5%-0.4%-0.5%2.8×
Q2 FY1715 Nov 2016-2.6%-9.9%-9.9%2.4×
Q1 FY171 Oct 2016+0.4%0.0%-1.7%1.7×
Q4 FY1627 May 2016+0.2%+11.7%+23.8%4.9×
Q3 FY1618 Feb 20160.0%-3.8%+2.3%0.5×
Q2 FY1613 Nov 2015-0.1%+5.4%+11.3%0.7×
Q1 FY1612 Aug 2015-5.6%-3.3%-9.6%1.6×
Q4 FY1515 Jun 2015-0.8%+7.3%+12.6%0.4×
Q3 FY1517 Feb 2015-0.1%-3.2%+54.3%0.2×
Q2 FY1521 Nov 2014-1.7%-1.3%+0.9%0.8×
Q1 FY1520 Aug 2014-1.1%+7.3%+33.2%0.8×
Q4 FY143 Jun 2014-1.1%+7.2%+33.2%0.3×
Q3 FY1420 Feb 2014-1.1%+7.8%+4.4%0.5×
Q2 FY1422 Nov 2013+1.5%+1.3%+6.5%0.7×
Q1 FY1421 Aug 2013+1.2%-0.2%+5.2%0.6×
Q4 FY138 Jun 20130.0%+3.7%+6.9%0.2×
Q3 FY1320 Feb 2013-0.5%-4.0%-1.9%0.1×
Q2 FY138 Nov 2012+2.5%+5.4%+22.2%8.2×
Q1 FY1313 Aug 2012+1.7%-3.2%+4.9%1.1×
Q4 FY1229 May 2012-1.8%-9.7%-15.3%1.1×
Q3 FY129 Feb 2012+1.6%+2.5%+14.6%3.9×
Q2 FY129 Nov 2011-3.0%-11.7%+4.2%0.3×
Q1 FY1217 Aug 2011-0.9%-0.2%-6.2%0.5×
Q4 FY113 Jun 2011-1.0%-1.0%-5.2%0.5×
Q3 FY1114 Feb 2011+0.3%-6.5%-7.7%1.3×
Q2 FY1115 Nov 2010-0.5%+0.6%-1.4%0.6×
Q1 FY1131 Jul 2010-0.6%+2.8%+35.2%0.4×
Q4 FY1025 Jun 2010+3.0%+9.3%+4.7%2.9×
Q3 FY1027 Jan 2010+0.2%+1.8%+7.4%0.5×
Q2 FY1029 Oct 2009-2.8%-4.6%-4.6%0.7×
Q1 FY1030 Jul 2009-4.0%-4.6%+31.9%0.8×
Q4 FY0930 Jun 2009-2.7%-4.3%-1.8%0.6×
Q3 FY0927 Jan 2009+6.5%+4.3%+3.8%2.6×
Q2 FY0931 Oct 2008+9.2%+18.4%+20.7%1.1×
Q1 FY0931 Jul 2008-0.7%+10.9%+5.5%0.7×
Q4 FY0830 Jun 2008-1.3%-7.4%-2.0%1.3×
Q3 FY0825 Jan 2008-3.0%+1.7%-8.7%0.2×
Q2 FY0826 Oct 2007-0.2%+0.6%+3.1%1.0×
Q1 FY0826 Jul 2007-0.8%-6.8%-17.0%1.5×
Q4 FY0729 Jun 2007-6.4%-11.5%-19.1%1.6×
Average-1.0%-1.1%+2.6%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY-29.0%
Profit YoY-60.9%
Interest cost YoY+65.0%
Revenue QoQ+31.6%
Profit QoQ-1.9%
CAGR2Y3Y4Y5Y6Y7Y
Revenue-17.7%-4.6%+5.7%+15.9%+5.0%+6.5%
Profit-34.7%-9.8%+19.4%+26.5%+7.9%+6.2%

Key data

Open821.95
Day range810.00 – 831.60
52-week range773.60 – 1,226.80
From 52w high-33.6%
RSI (14)54.0
ATR (14)23.30
Volume5.59L
Avg volume (20D)8.51L
Rel volume0.66×
Volatility (1Y)36.1%
Turnover₹45.7Cr
Traded value (NSE)₹45.7Cr
VWAP817.87
SMA 50 / 200807.86 / 926.10
Price band20%

Delivery percentage

Latest · 20 Nov 202648.3%
20-day avg50.6%
1-year avg41.6%
Percentile (own history)40th
Range7.6–98.7%
Sessions3,603

Over the last 20 sessions NATCOPHARM settled 50.6% of its traded quantity, which is above average for an NSE equity. Its one-year average is 41.6%, so recent sessions are running 9.1 points higher than usual. The latest session ranks higher than 40% of the 3,603 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.52%
Dividend, trailing 12M₹4.25
Paid every year for10+ yr
Shareholders4.04L · +0.1% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy359 days ago

Performance returns

1D1W1M3M6M1Y
Price-0.93%+0.48%+3.71%-7.20%-30.66%+0.20%

Valuation

Market cap₹15,974 Cr
Market cap (NSE)₹15,974 Cr
Free-float cap₹8,591 Cr
P/E (TTM)19.3
P/E (NSE)19.4
EPS (TTM)42.23
P/B1.6
Net margin (TTM)26.8%
Other income / PBT33.7%
ROE9.0%
Debt / equity0.11
Shares outstanding17.90Cr
Listed27 Dec 1995

Ownership

Promoter46.22%
Promoter Δ QoQ-3.17 pp
Public53.78%
FII15.36%
DII10.82%
Pledged0.94%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)647.3739.1735.2967.3
YoY chg+36.3%-39.5%-44.7%-29.0%
Net profit (₹ Cr)151.3269.0206.5202.6
YoY chg+14.3%-33.7%-57.0%-60.9%
Net margin23.4%36.4%28.1%20.9%
EPS8.4614.9611.5311.31

Shareholding over time

By quarter

23 Oct 2026 · promoter 46.22% · public 53.78%
30 Sept 2021: promoter 48.87%31 Dec 2021: promoter 48.86%31 Mar 2022: promoter 48.81%30 Jun 2022: promoter 48.80%30 Sept 2022: promoter 48.80%31 Dec 2022: promoter 48.82%31 Mar 2023: promoter 48.84%30 Jun 2023: promoter 49.76%30 Sept 2023: promoter 49.71%31 Dec 2023: promoter 49.71%31 Mar 2024: promoter 49.71%30 Jun 2024: promoter 49.71%30 Sept 2024: promoter 49.62%31 Dec 2024: promoter 49.62%31 Mar 2025: promoter 49.56%30 Jun 2025: promoter 49.56%30 Sept 2025: promoter 49.48%31 Dec 2025: promoter 49.48%31 Mar 2026: promoter 49.42%30 Jun 2026: promoter 49.42%30 Sept 2026: promoter 49.39%23 Oct 2026: promoter 46.22%
2021-092026-10
  • Promoter
  • Public and others
Promoter
46.22%
Public
53.78%
Promoter change
-3.17 pp
Filed
1 Nov 2026
FII
15.36%
DII
10.82%
Promoter pledged
0.94%

Who the public is

Mutual funds
7.01%

+4.76 pp QoQ

Insurance
3.57%

-0.23 pp QoQ

FPI
15.37%

-0.62 pp QoQ

Retail ≤ ₹2L
19.59%

-1.05 pp QoQ

HNI > ₹2L
3.18%

-0.04 pp QoQ

NRI
1.66%

-0.06 pp QoQ

Bodies corporate
1.50%

-0.09 pp QoQ

Shareholders
4,04,384

+0.1% QoQ

Major holders

As of 23 Oct 2026
HolderTypeHolding
V C NANNAPANENIPromoter · Individual14.60%
TIME CAP PHARMA LABS PRIVATE LIMITEDPromoter · Corporate9.23%
NATSOFT INFORMATION SYSTEMS PVT LTDPromoter · Corporate8.17%
VENKATA SATYA SWATHI KANTAMANIPromoter · Individual8.15%
TATA MUTUAL FUNDMutual fund2.58%
BELGRAVE INVESTMENT FUNDFPI2.42%
Vistra ITCL India Limited A/c Neelima Nannapaneni TrustPromoter · Other2.12%
LIFE INSURANCE CORPORATION OF INDIAInsurance2.04%
DURGA DEVI NANNAPANENIPromoter · Individual1.78%
ICICI PrudentialMutual fund1.61%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 22 Feb 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-272₹2.75₹2.75
FY2025-263₹5.00₹5.00
FY2024-253₹6.00₹6.00
FY2023-243₹9.50₹9.50
FY2022-233₹5.50₹5.50
FY2021-223₹4.50₹4.50
FY2020-214₹6.25₹6.25
FY2019-204₹7.00₹7.00
FY2018-192₹5.00₹5.00
FY2017-182₹8.25₹8.25
FY2016-172₹6.75₹6.75
FY2015-161₹1.25₹1.25
FY2014-151₹5.00₹1.00
FY2013-141₹5.00₹1.00
FY2012-131₹4.00₹0.80
FY2011-121₹3.00₹0.60
Ex-dateRecord dateDeclaredAdjusted
19 Nov 202619 Nov 2026₹1.25₹1.25
20 Aug 2026—₹1.50₹1.50
18 Feb 2026—₹1.50₹1.50
20 Nov 2025—₹1.50₹1.50
19 Aug 2025—₹2.00₹2.00
18 Feb 2025—₹1.50₹1.50
27 Nov 2024—₹1.50₹1.50
23 Aug 2024—₹3.00₹3.00
26 Feb 2024—₹1.25₹1.25
24 Nov 2023—₹1.25₹1.25
22 Aug 2023—₹7.00₹7.00
21 Feb 2023—₹1.25₹1.25
21 Nov 2022—₹0.75₹0.75
19 Aug 2022—₹3.50₹3.50
24 Feb 2022—₹2.00₹2.00
23 Nov 2021—₹0.50₹0.50
24 Aug 2021—₹2.00₹2.00
22 Feb 2021—₹1.00₹1.00
24 Nov 2020—₹3.00₹3.00
21 Aug 2020—₹1.25₹1.25
26 Jun 2020—₹1.00₹1.00
24 Feb 2020—₹3.50₹3.50
21 Nov 2019—₹1.00₹1.00
22 Aug 2019—₹1.25₹1.25
6 Jun 2019—₹1.25₹1.25
21 Feb 2019—₹3.50₹3.50
20 Aug 2018—₹1.50₹1.50
15 Feb 2018—₹7.00₹7.00
16 Aug 2017—₹1.25₹1.25
23 Feb 2017—₹6.00₹6.00
19 Aug 2016—₹0.75₹0.75
22 Feb 2016—₹1.25₹1.25
24 Feb 2015—₹5.00₹1.00
24 Feb 2014—₹5.00₹1.00
22 Feb 2013—₹4.00₹0.80
22 Feb 2012—₹3.00₹0.60

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
3.9 years ago
Disclosures on record
175
55 open-market of the newest 100
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
11 Mar 2026SANJAY NANNAPANENIPromoterSell70.0K₹7.1Cr1,017.312.27L → 1.57L0.09%-0.04 pp7(2)told 11 Mar 2026
11 Mar 2026SATYA VANI NANNAPANENIPromoterSell45.0K₹4.5Cr1,001.333.80L → 3.35L0.19%-0.03 pp7(2)told 11 Mar 2026
1 Oct 2025SANJAY NANNAPANENIPromoterSell1.00L₹8.0Cr803.053.27L → 2.27L0.13%-0.06 pp7(2)told 1 Oct 2025
17 Sept 2025SATYA VANI NANNAPANENIPromoterSell23.0K₹2.0Cr857.394.03L → 3.80L0.21%-0.01 pp7(2)told 17 Sept 2025
11 Sept 2025SATYA VANI NANNAPANENIPromoterSell17.1K₹1.5Cr846.684.20L → 4.03L0.22%-0.01 pp7(2)told 11 Sept 2025
12 Jun 2025PRAGNYA RAO DONTHINENIOtherBuy100₹86,500865.00303 → 4030.00%0.00 pp7(2)told 11 Jun 2025
31 Dec 2024Lakshminarayana BolisettyDirectorSell2.0K₹27.8L1,391.612.0K → —0.00%7(2)told 31 Dec 2024
31 Dec 2024TUMMALA VENKAT RAOEmployeeSell2.5K₹34.5L1,380.3864.4K → 61.9K0.03%-0.00 pp7(2)told 30 Dec 2024
21 Dec 2024SADA SIVA RAO. NANNAPANENIEmployeeSell5.0K₹73.4L1,467.2276.1K → 71.1K0.04%-0.00 pp7(2)told 20 Dec 2024
2 Dec 2024TUMMALA RAHULOtherSell1.0K₹13.5L1,352.861.0K → —0.00%7(2)told 30 Nov 2024
28 Nov 2024TUMMALA RAHULOtherSell900₹12.2L1,359.241.9K → 1.0K0.00%0.00 pp7(2)told 28 Nov 2024
12 Sept 2024AMIT SOGANIOtherSell1.5K₹24.3L1,617.571.5K → —0.00%7(2)told 12 Sept 2024
6 Sept 2024SUNIL KOTARUOtherSell1.3K₹20.4L1,556.624.3K → 3.0K0.00%0.00 pp7(2)told 6 Sept 2024
5 Sept 2024G VENKATA RAMANAOtherSell2.0K₹30.7L1,533.028.2K → 6.2K0.00%0.00 pp7(2)told 5 Sept 2024
2 Sept 2024M SUBBA RAOOtherSell20.0K₹3.0Cr1,514.0055.1K → 35.1K0.02%-0.01 pp7(3)told 31 Aug 2024
26 Aug 2024DHRUVA KUMAR NANNAPANENIRelativeSell600₹9.4L1,560.091.4K → 7750.00%0.00 pp7(2)told 26 Aug 2024
22 Aug 2024N SRILAKSHMIRelativeSell10.0K₹1.5Cr1,456.1361.0K → 51.0K0.03%-0.01 pp7(2)told 22 Aug 2024
21 Aug 2024ANILA TPromoterSell35.0K₹5.0Cr1,437.466.00L → 5.65L0.32%-0.02 pp7(2)told 21 Aug 2024
21 Aug 2024VIDYADHARI TUMMALAPromoterSell75.0K₹10.9Cr1,458.754.42L → 3.67L0.21%-0.04 pp7(2)told 21 Aug 2024
21 Aug 2024RATNAKUMAR KPromoterSell38.4K₹5.6Cr1,460.4888.4K → 50.0K0.03%-0.02 pp7(2)told 20 Aug 2024
21 Aug 2024RATNAKUMAR KPromoterSell11.6K₹1.7Cr1,460.481.00L → 88.4K0.05%-0.01 pp7(2)told 20 Aug 2024
29 Jun 2024PULLAREDDY MUDDASANIEmployeeSell500₹5.9L1,170.6344.6K → 44.1K0.02%-0.00 pp7(2)told 29 Jun 2024
26 Jun 2024SANDEEP KURRAOtherSell17₹20,4001,200.0017 → —0.00%7(2)told 26 Jun 2024
26 Jun 2024VENKATA SREENIVASABABU KURRAEmployeeSell2.4K₹28.9L1,197.942.4K → —0.00%7(2)told 26 Jun 2024
26 Jun 2024SUNIL KOTARUEmployeeSell840₹10.1L1,202.405.2K → 4.3K0.00%0.00 pp7(2)told 25 Jun 2024
26 Jun 2024TUMMALA VENKAT RAOEmployeeSell400₹4.8L1,207.3064.8K → 64.4K0.04%-0.00 pp7(2)told 26 Jun 2024
25 Jun 2024POTLURI SIVA RAMA KRISHNA PRASADDirectorSell5.0K₹60.0L1,200.0046.1K → 41.1K0.02%-0.00 pp7(2)told 25 Jun 2024
21 Jun 2024PRAVEEN CHOWDARY MYNENIEmployeeSell999₹11.7L1,174.7010.4K → 9.4K0.00%0.00 pp7(2)told 20 Jun 2024
4 Jun 2024PRATIMA JAINEmployeeSell1.4K₹13.7L998.901.4K → —0.00%7(2)told 4 Jun 2024
29 Dec 2023LINGA RAO DDirectorSell10.0K₹80.0L799.9964.2K → 54.2K0.03%-0.01 pp7(2)told 29 Dec 2023
28 Dec 2023TUMMALA RAHULOtherSell100₹81,275812.752.0K → 1.9K0.00%0.00 pp7(3)told 28 Dec 2023
23 Dec 2023LAKSHMI NARAYANA AREEmployeeSell1.5K₹12.0L800.0012.6K → 11.1K0.00%0.00 pp7(2)told 23 Dec 2023
15 Dec 2023PATIL CHANDRASEKHARA REDDYEmployeeSell1.1K₹8.5L784.001.1K → 500.00%0.00 pp7(2)told 15 Dec 2023
13 Dec 2023PATIL CHANDRASEKHARA REDDYEmployeeSell4.1K₹32.2L780.825.3K → 1.1K0.00%0.00 pp7(2)told 12 Dec 2023
11 Dec 2023POTLURI SIVA RAMA KRISHNA PRASADDirectorSell10.0K₹79.3L792.9156.1K → 46.1K0.03%-0.01 pp7(2)told 11 Dec 2023
4 Dec 2023JAYA POTLURIOtherSell1.7K₹13.1L774.571.7K → —0.00%7(3)told 4 Dec 2023
4 Dec 2023NDL INFRATECH PVT LTDPromoterSell300₹2.3L771.4094.0K → 93.8K0.05%-0.00 pp7(2)told 4 Dec 2023
22 Nov 2023LAKSHMI NARAYANA AREEmployeeSell2.0K₹15.7L784.1414.6K → 12.6K0.01%-0.00 pp7(2)told 22 Nov 2023
4 Oct 2023VANAJA MUDDASANIRelativeSell900₹8.0L891.565.2K → 4.3K0.00%0.00 pp7(2)told 3 Oct 2023
6 Sept 2023PURANDHAR TOtherSell25.0K₹2.3Cr900.012.59L → 2.34L0.13%-0.01 pp7(3)told 6 Sept 2023
6 Sept 2023ANILA TPromoterSell30.0K₹2.7Cr904.856.30L → 6.00L0.33%-0.02 pp7(2)told 6 Sept 2023
6 Sept 2023ANANDA BABU TPromoterSell60.0K₹5.4Cr903.744.73L → 4.13L0.23%-0.03 pp7(2)told 6 Sept 2023
22 Feb 2023NITEESHRAO MADHAVARAMOtherBuy10₹5,361536.10125 → 1350.00%0.00 pp7(3)told 22 Feb 2023
20 Feb 2023NITEESHRAO MADHAVARAMOtherBuy55₹29,150530.0070 → 1250.00%0.00 pp7(3)told 20 Feb 2023
20 Feb 2023PRAGNYA RAO DONTHINENIOtherBuy303₹1.6L530.41— → 3030.00%7(3)told 20 Feb 2023
20 Dec 2022V C NANNAPANENIPromoterBuy9.1K₹49.8L550.802.26Cr → 2.26Cr12.38%+0.00 pp7(2)told 20 Dec 2022
2 Dec 2022NATSOFT INFORMATION SYSTEMPS PVT LTDPromoterBuy17.4K₹99.4L571.491.58Cr → 1.58Cr8.65%+0.01 pp7(2)told 2 Dec 2022
1 Dec 2022V C NANNAPANENIPromoterBuy8.9K₹49.9L562.152.26Cr → 2.26Cr12.38%+0.00 pp7(2)told 1 Dec 2022
29 Mar 2022NDL INFRATECH PVT LTDPromoterBuy300₹2.6L870.3293.8K → 94.0K0.05%+0.00 pp7(2)told 28 Mar 2022
4 Mar 2022PULLAREDDY MUDDASANIEmployeeBuy500₹4.0L806.6038.1K → 38.6K0.02%+0.00 pp7(2)told 3 Mar 2022
4 Mar 2022BIKKUMALLA SRINIVASA RAOEmployeeSell350₹3.1L884.00350 → —0.00%7(2)told 4 Mar 2022
25 Aug 2021ADINARAYANA MADINEEDIKMPBuy340₹3.1L900.9740.7K → 41.0K0.02%+0.00 pp7(2)told 25 Aug 2021
25 Aug 2021SUSEELA PINNAMANENIRelativeBuy246₹2.2L894.018.8K → 9.0K0.00%0.00 pp7(2)told 25 Aug 2021
25 Aug 2021SRILAKSHMI PINNAMANENIRelativeBuy150₹1.3L899.6217.9K → 18.0K0.01%+0.00 pp7(2)told 25 Aug 2021
23 Aug 2021TUMMALA VENKAT RAOEmployeeBuy1.0K₹9.1L910.5263.8K → 64.8K0.03%+0.00 pp7(2)told 23 Aug 2021

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 26 Nov 2025

CSV
12 of 53 deals
By year
DateDealClientQuantityPriceValue
26 Nov 2025Sell · bulkGRAVITON RESEARCH CAPITAL LLP11.99L904.93₹108.5Cr
26 Nov 2025Buy · bulkGRAVITON RESEARCH CAPITAL LLP11.99L904.19₹108.4Cr
24 Apr 2025Sell · bulkGRAVITON RESEARCH CAPITAL LLP17.85L930.19₹166.0Cr
24 Apr 2025Buy · bulkGRAVITON RESEARCH CAPITAL LLP17.85L929.71₹165.9Cr
14 Feb 2025Sell · bulkGRAVITON RESEARCH CAPITAL LLP9.72L891.03₹86.6Cr
14 Feb 2025Buy · bulkGRAVITON RESEARCH CAPITAL LLP9.72L890.86₹86.6Cr
3 Oct 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO1.88L605.80₹11.4Cr
3 Oct 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF1.88L605.80₹11.4Cr
3 Oct 2022Sell · blockISHARES INDIA SC MAURITIUS COMPANY22.2K605.80₹1.3Cr
3 Oct 2022Buy · blockISHARES MSCI INDIA SMALL-CAP ETF22.2K605.80₹1.3Cr
20 Jun 2014Buy · bulkMV SCIF MAURITIUS1.75L1,149.56₹20.1Cr
29 Jul 2013Sell · bulkMERRILL LYNCH CAPITAL MARKET ESPANA SA SV2.00L589.55₹11.8Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to NATCOPHARM.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations758.61,068.31,362.61,371.1474.81,221.01,328.91,363.0647.3739.1735.2967.3
Other income37.042.048.163.8176.366.361.7100.058.177.859.252.1
Total income795.61,110.31,410.71,434.9651.11,287.31,390.61,463.0705.4816.9794.41,019.4
Total expenses539.3632.7607.1616.7487.4781.4818.7849.3544.3672.8608.8776.2
└ Finance costs4.66.25.24.14.410.23.213.19.510.913.017.6
└ Depreciation44.255.544.145.847.098.357.652.446.250.447.149.2
Profit before tax256.3477.6803.6818.2163.7505.9571.9613.7161.1144.1185.6243.2
Tax expense43.691.3135.1141.731.399.991.695.820.7(89.2)63.469.8
Net profit212.7386.3668.5676.5132.4406.0480.3517.9151.3269.0206.5202.6
EPS11.8821.5637.3237.817.4322.7026.8428.948.4614.9611.5311.31
Net margin28.04%36.16%49.06%49.34%27.89%33.25%36.14%38.00%23.37%36.40%28.09%20.94%
PBT margin33.79%44.71%58.98%59.67%34.48%41.43%43.04%45.03%24.89%19.50%25.24%25.14%
Tax rate17.01%19.12%16.81%17.32%19.12%19.75%16.02%15.61%12.85%-61.90%34.16%28.70%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 13 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets5,657.46,254.06,906.38,244.78,630.810,430.111,073.711,798.8
Current assets3,000.33,349.74,023.55,001.55,270.06,966.75,052.34,234.9
└ Cash & equivalents131.9104.070.4104.6120.0103.5198.9138.5
└ Other bank balances414.4615.5882.51,457.52,056.02,586.71,352.0930.5
└ Current investments305.0299.5443.5474.4320.8514.1578.2448.3
└ Trade receivables856.11,119.81,188.91,435.71,246.61,718.9881.2803.4
└ Inventories742.9709.8700.5774.6765.8818.0908.51,006.2
Total equity4,873.85,293.55,853.17,156.87,612.38,654.29,221.19,764.7
└ Attributable to owners4,873.85,293.55,853.17,149.97,607.08,649.89,221.19,764.7
└ Non-controlling interest———6.95.34.40.0—
└ Share capital36.535.835.835.835.835.835.835.8
Borrowings165.0238.8363.2201.0273.1252.8706.41,026.7
└ Current165.0238.8363.2201.0273.1252.8606.41,026.7
└ Non-current0.00.00.00.00.00.0100.00.0
Trade payables263.8366.1235.5314.4274.9512.6409.3424.4
Current liabilities683.1878.3972.81,008.7943.51,700.01,680.91,950.3
Total liabilities783.6960.51,053.21,087.91,018.51,775.91,852.62,034.1
Net debt(686.3)(780.2)(1,033.2)(1,835.5)(2,223.7)(2,951.5)(1,422.7)(490.6)
Debt / equity0.030.050.060.030.040.030.080.11
Current ratio4.393.814.144.965.594.103.012.17

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow849.1632.31,211.61,137.01,696.81,190.61,768.3165.0
└ Capex(205.6)(166.3)(358.7)(240.1)(511.6)(184.0)(391.1)(307.5)
Free cash flow643.5466.0852.9896.91,185.21,006.61,377.2(142.5)
Investing cash flow(477.1)(347.8)(1,032.7)(881.7)(1,414.5)(1,188.7)(2,142.9)(504.8)
Financing cash flow(363.0)(314.4)(246.9)(219.1)(210.7)(76.5)297.5261.4
└ Dividends paid(100.4)(125.5)(170.8)(53.8)(107.8)(36.2)(90.2)(27.1)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash9.0(29.9)(68.0)36.271.6(74.6)(77.1)(78.4)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

NATCOPHARM at a glance

  • NATCOPHARM closed at ₹814.3 on 20 Nov 2026, -0.93% on the day, +0.2% over one year, 33.6% below its 52-week high of ₹1,226.8.
  • Delivery was 48.3% of traded quantity on 20 Nov 2026, the 40th percentile of its own 3,603 sessions with a reading (20-session average 50.6%, 1-year average 41.6%).
  • Market capitalisation is ₹15,974 crore at a trailing P/E of 19.3 (trailing EPS ₹42.23).
  • Q2 FY27 results (consolidated, filed 13 Nov 2026): revenue ₹967 crore (-29.0% year on year), net profit ₹203 crore (-60.9%); the price moved +0.2% on the first session after.
  • Promoters held 46.22% at 23 Oct 2026, down 3.17 percentage points on the previous filing, with 0.94% of promoter shares pledged.
  • Q3 FY27 results are expected between 9 Feb 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE987B01026
SeriesEQ
Listed27 Dec 1995
NSE market cap · 17 Nov 2026₹16,143 Cr
Free-float market cap (NSE)₹8,076 Cr
Shares outstanding (NSE)19.62Cr
History from27 Dec 1995
Sessions7,634
Turnover rank#361

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.